Better Healthcare Newsletter from Patrick Malone - July 2021

Patrick Malone & Associates P.C. | DC Injury Lawyers
Contact

When we get sick, all too many of us respond reflexively: Ring up the doctor, wolf down some prescribed pills, and everything, we hope and trust, will turn out fine.

That approach is problematic on many levels, especially because it often does not work. Big Pharma may be riding high these days, what with its development of miraculous coronavirus vaccines. But drug makers absolutely have not come up with treatments for all of humanity’s major ills.

This is especially true with dementia and the cognitive condition’s best-known form: Alzheimer’s disease. Sure, the news has been full of reports that the federal Food and Drug Administration just granted an accelerated approval to a prescription medication from Biogen aimed at Alzheimer’s — the first such drug to win such an endorsement in a decade.

Please see full Newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patrick Malone & Associates P.C. | DC Injury Lawyers | Attorney Advertising

Written by:

Patrick Malone & Associates P.C. | DC Injury Lawyers
Contact
more
less

Patrick Malone & Associates P.C. | DC Injury Lawyers on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.